Anna L Brown

28PUBLICATIONS
163CO-AUTHORS
Predictive and prognostic markersRegenerative medicine (incl. stem cells)Medical virologyHaematological tumoursEpigenetics (incl. genome methylation and epigenomics)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (28)

|May 22, 2025
RAS mutation identifies a poor prognostic molecular subtype of therapy-related myeloid neoplasm.

Chung Hoow Kok, Aref Al-Kali, Daniel Thomas

|May 07, 2025
Validation of the 5th edition of the World Health Organization and International Consensus Classification guidelines for TP53-mutated myeloid neoplasm in an independent international cohort.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

|Apr 23, 2025
RBC transfusion dependency refines the Molecular International Prognostic Scoring System for myelodysplastic syndrome.

Thomas Wiseman, Michaela Spooner, Shreyas Khanna

|Mar 14, 2025
Evidence-based risk stratification of myeloid neoplasms harboring TP53 mutations.

Mithun Vinod Shah, Kevin Hung, Anmol Baranwal

|Jul 19, 2024
Myeloid neoplasms arising after methotrexate therapy for autoimmune rheumatological diseases do not exhibit poor-risk molecular features.

Mihir D Wechalekar, Lin-Pierre Zhao, Monika M Kutyna

|Jul 11, 2024
Germ line ERG haploinsufficiency defines a new syndrome with cytopenia and hematological malignancy predisposition.

Jiarna R Zerella, Claire C Homan, Peer Arts

Pageof 5

Frequent Collaborators

19 joint publications

Hamish Scott

17 joint publications

Christopher N Hahn

7 joint publications

Mithun Vinod Shah

7 joint publications

Mrinal Patnaik